Does Rallies show 13F holders for CELU?

Yes. Rallies tracks hedge fund and 13F ownership data for CELU, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CELU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CELU. It does not provide personalized investment advice.

CELU (Celularity Inc. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

Celularity Inc. Class A Common Stock (CELU) is a publicly traded Healthcare sector company. As of May 21, 2026, CELU trades at $0.89 with a market cap of $23.11M and a P/E ratio of -0.31. CELU moved +4.21% today. Year to date, CELU is -34.51%; over the trailing twelve months it is -64.58%. Its 52-week range spans $0.71 to $5.22. Rallies surfaces CELU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CELU stock?

Hedge funds tracked by Rallies that own CELU include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Celularity Inc. Class A Common Stock.

CELU Key Metrics

Key financial metrics for CELU
Metric	Value
Price	$0.89
Market Cap	$23.11M
P/E Ratio	-0.31
EPS	$-2.64
Dividend Yield	0.00%
52-Week High	$5.22
52-Week Low	$0.71
Volume	274.84K
Avg Volume	0
Revenue (TTM)	$54.22M
Net Income	$-57.89M
Gross Margin	72.36%

Top Hedge Funds Holding CELU

Citadel Advisors holds 24.00K shares of CELU, changed +11900.00% as of Dec 31, 2024.
Renaissance Technologies holds 11.00K shares of CELU, changed -52.95% as of Dec 31, 2024.

Latest CELU News

Celularity Regains Nasdaq Compliance, Cuts $13M Liabilities After 2025 10-K — May 1, 2026
Celularity closes $13.3M asset sale to NexGel, retires $13M debt — Apr 21, 2026
Celularity to Manufacture Six Licensed Biomaterials and Three Pipeline Devices with NEXGEL by April 2026 — Mar 12, 2026
Celularity Raises $12.2M from Sale of $126.3M NOLs and R&D Tax Credits — Feb 10, 2026

CELU Analyst Consensus

CELU analyst coverage data. Average price target: $0.00.

Common questions about CELU

Who owns CELU stock?: Hedge funds tracked by Rallies that own CELU include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Celularity Inc. Class A Common Stock.
Does Rallies show 13F holders for CELU?: Yes. Rallies tracks hedge fund and 13F ownership data for CELU, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CELU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CELU. It does not provide personalized investment advice.